SourceOne Announces Start of Clinical Trial for Sytrinol(TM) and Plant Sterol Combination :: Natural and Nutritional Products Industry Center :: News

"SourceOne™ Global Partners, a sales and marketing company providing proprietary branded nutritional ingredients to manufacturers and marketers, has announced the launch of a double-blind, placebo-controlled, randomized study with its signature proprietary cardiovascular wellness compound, Sytrinol™. In addition to further validating the benefits of Sytrinol™ as a stand-alone compound, the study will include several arms with a combination of Sytrinol™ and plant sterols to further illuminate the strength of efficacy of these compounds as a compelling and potent combination dietary supplement. This study serves to provide dietary supplement manufacturers and marketers with the added flexibility and viability of providing consumers with effective cardiovascular formulas for specific lifestyles and levels of heart health concerns. The study will be conducted by Radiant Research Incorporated located in Chicago IL."

SourceOne Announces Start of Clinical Trial for Sytrinol(TM) and Plant Sterol Combination :: Natural and Nutritional Products Industry Center :: News